Patents by Inventor Marie-Agnes DOUCEY

Marie-Agnes DOUCEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD47-CD38 BISPECIFIC ANTIBODIES
    Publication number: 20240150489
    Abstract: Novel bispecific heterodimeric immunoglobulins that target both a component of the human CD47 antigen and human CD38 antigen are provided and in particular those comprising an anti-CD38 heavy chain variable region and a light chain variable region and an anti-CD47 heavy chain variable region and a light chain variable region. The present invention also relates to the use of this novel class of bispecific heterodimeric immunoglobulins to treat autoimmune and proliferative diseases and in particular cancers such as hematologic malignancies and solid tumors.
    Type: Application
    Filed: October 11, 2023
    Publication date: May 9, 2024
    Inventors: Laure BOUCHEZ, Blandine POULEAU, Marie-Agnes DOUCEY, Elie DHEILLY, Stanislas BLEIN, Cian STUTZ, Carole ESTOPPEY, Jeremy LOYAU, Thierry MONNEY, Camille GRANDCLEMENT, Stefano SAMMICHELI
  • CD47-CD38 BISPECIFIC ANTIBODIES
    Publication number: 20240141062
    Abstract: Novel bispecific heterodimeric immunoglobulins that target both a component of the human CD47 antigen and human CD38 antigen are provided and in particular those comprising an anti-CD38 heavy chain variable region and a light chain variable region and an anti-CD47 heavy chain variable region and a light chain variable region. The present invention also relates to the use of this novel class of bispecific heterodimeric immunoglobulins to treat autoimmune and proliferative diseases and in particular cancers such as hematologic malignancies and solid tumors.
    Type: Application
    Filed: October 11, 2023
    Publication date: May 2, 2024
    Inventors: Laure BOUCHEZ, Blandine POULEAU, Marie-Agnes DOUCEY, Elie DHEILLY, Stanislas BLEIN, Cian STUTZ, Carole ESTOPPEY, Jeremy LOYAU, Thierry MONNEY, Camille GRANDCLEMENT, Stefano SAMMICHELI, Cyrille DREYFUS
  • Antibodies that bind to IL1RAP and uses thereof
    Patent number: 11970539
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and may also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: April 30, 2024
    Assignee: Ichnos Sciences SA
    Inventors: Julie Macoin, Amelie Croset, Jeremy Loyau, Thierry Monney, Lamine Mbow, Marie-Agnes Doucey, Valentina Labanca
  • CD47-CD38 BISPECIFIC ANTIBODIES
    Publication number: 20220089767
    Abstract: Novel bispecific heterodimeric immunoglobulins that target both a component of the human CD47 antigen and human CD38 antigen are provided and in particular those comprising an anti-CD38 heavy chain variable region and a light chain variable region and an anti-CD47 heavy chain variable region and a light chain variable region. The present invention also relates to the use of this novel class of bispecific heterodimeric immunoglobulins to treat autoimmune and proliferative diseases and in particular cancers such as hematologic malignancies and solid tumors.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 24, 2022
    Inventors: Laure Bouchez, Blandine Pouleau, Marie-Agnes Doucey, Elie Dheilly, Stanislas Blein, Cian Stutz, Carole Estoppey, Jeremy Loyau, Thierry Monney, Camille Grandclement, Stefano Sammicheli
  • ANTIBODIES THAT BIND TO IL1RAP AND USES THEREOF
    Publication number: 20220089754
    Abstract: The present invention relates to antibodies which specifically bind to human IL1RAP and my also bind to cynomolgus monkey and/or mouse IL1RAP. The present invention also relates to the use of such antibodies to diagnose and treat human disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: March 24, 2022
    Inventors: Julie MACOIN, Amelie CROSET, Jeremy LOYAU, Thierry MONNEY, Lamine MBOW, Marie-Agnes DOUCEY, Valentina LABANCA
  • Adoptive immunotherapy for treating cancer
    Patent number: 10858626
    Abstract: The present invention provides methods for producing and/or expanding tumor-infiltrating lymphocytes (TILs) that can be used in adoptive immunotherapy in cancer treatment.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: December 8, 2020
    Assignee: UNIVERSITÉ DE LAUSANNE
    Inventors: Marie-Agnes Doucey, Nicolas Guex, Isaac Crespo, Ioannis Xenarios
  • ADOPTIVE IMMUNOTHERAPY FOR TREATING CANCER
    Publication number: 20170349880
    Abstract: The present invention provides methods for producing and/or expanding tumor-infiltrating lymphocytes (TILs) that can be used in adoptive immunotherapy in cancer treatment.
    Type: Application
    Filed: December 15, 2015
    Publication date: December 7, 2017
    Applicant: UNIVERSITÉ DE LAUSANNE
    Inventors: Marie-Agnes DOUCEY, Nicolas GUEX, Isaac CRESPO, Ioannis XENARIOS